Sg Americas Securities, LLC Precision Biosciences Inc Transaction History

Sg Americas Securities, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$0.97 - $45.0 $2,278 - $105,705	-2,349 Reduced 12.46%	16,508 $20,000
Q3 2022 Oct 31, 2022	BUY	$1.22 - $40.8 $1,484 - $49,653	1,217 Added 6.9%	18,857 $25,000
Q2 2022 Jul 29, 2022	BUY	$1.15 - $3.34 $7,841 - $22,775	6,819 Added 63.02%	17,640 $28,000
Q1 2022 Apr 29, 2022	BUY	$2.96 - $7.76 $32,030 - $83,970	10,821 New	10,821 $33,000
Q4 2021 Feb 07, 2022	SELL	$7.4 - $11.66 $164,435 - $259,096	-22,221 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$9.18 - $14.15 $203,988 - $314,427	22,221 New	22,221 $256,000
Q2 2021 Aug 12, 2021	SELL	$8.07 - $12.52 $80,078 - $124,235	-9,923 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$8.57 - $15.79 $85,040 - $156,684	9,923 New	9,923 $103,000
Q3 2020 Nov 09, 2020	SELL	$4.65 - $8.73 $115,915 - $217,621	-24,928 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$4.66 - $8.7 $51,390 - $95,943	11,028 Added 79.34%	24,928 $208,000
Q1 2020 Apr 30, 2020	BUY	$5.05 - $15.01 $70,195 - $208,639	13,900 New	13,900 $84,000
Q2 2019 Jul 29, 2019	SELL	$11.88 - $16.94 $95,040 - $135,520	-8,000 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$17.44 - $17.95 $139,520 - $143,600	8,000 New	8,000 $144,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $539M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.